Cape Town drug company Afrigen has become the first African laboratory to partner with the US government’s Vaccine Research Centre to develop mRNA vaccine technology in SA and low-income countries.
The collaboration, announced on Friday, also comes after SA scientists led by Prof Patrick Arbuthnot, head of Wits University’s antiviral gene therapy research unit, were able to create an mRNA vaccine against Covid-19 from limited publicly available information. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.